Request Discount

Albumin Market (Source - Animal Sources, and Plant Sources; Type - Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin; Application - Drug Delivery, Therapeutic, Culture Media, and Vaccine Ingredient; End User - Pharmaceutical & Biotechnology, Research Institutes, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2024

  • Published : January, 2019

  • Rep Id : HC0340

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Albumin Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Albumin Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Albumin Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on albumin market provides in-depth analysis of segments and sub-segments in the global as well as regional albumin market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional albumin market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global albumin market. According to the report, the global albumin market is projected to grow at a CAGR of 6.8% over the forecast period of 2018-2024.

Global Albumin Market

Market Insight

Albumin is a water-soluble protein founded in blood plasma. It acts as a transponder for various substances such as hormones, vitamins, and enzymes. It plays a predominant role in regulating blood function. Albumin has a different application like the stabilizer, antibacterial, antioxidant, the universal carrier in rheumatoid arthritis and plays a role in the delivery of anticancer drugs. Serum albumin is the most abundant blood plasma protein. Human serum albumin and bovine serum albumin are different type’s serum albumin that is obtained from human plasma and bovine plasma, respectively.

Growing occurrence of rare diseases, shocks, trauma, liver conditions, burns, and other injury or surgery is the key factor that promotes the growth of the albumin market. Albumin is used to replace blood volume loss resulting from trauma such as severe burns or an injury that causes blood loss. Moreover, the rising consumption of albumin in various application such as drug discovery, drug formulation, and vaccines contributes to the growth of this market. Albumin has been used to prepare microcapsules for drug delivery system.

Apart from this, expanding awareness about the benefits of albumin, the rise in the non-therapeutic application of albumin and high demand for albumin in research and development activities are other key factors drives the growth of the market. However, the adverse effects associated with human serum albumin (HSA) administration and strict regulations criteria are hampering the growth of albumin market. The shift towards serum-free products is having a negative impact on the growth of the market. Furthermore, technological advancement in drug delivery and drug formulations creates significant opportunities for the albumin market.

North America and Europe region is expected to be the attractive market for albumin due to rapid development in the use of albumin for non-therapeutical applications. A large number of pharmaceutical companies and research institutes are more invested in life science is anticipated to escalate the growth of the market. Asia-Pacific is the fastest growing region in the albumin market owing to the growing awareness about albumin product. Countries such as China, India, Korea, and Japan are significantly focusing on medical research. The use of albumin for research purpose has a positive impact on the growth of albumin market in the Middle East and Africa region.

Segment Covered

The report on global albumin market covers segments such as source, type, application, and end user. On the basis of source, the sub-markets include animal sources and plant sources. On the basis of type, the sub-markets include human serum albumin bovine serum albumin and recombinant albumin. On the basis of application, the sub-markets include drug delivery, therapeutic, culture media, and vaccine ingredient. On the basis of the end user, the sub-markets include pharmaceutical & biotechnology, research institutes, and others.


Companies Profiled:

The report provides profiles of the companies in the market such as Baxalta Incorporated, Amgen, Biotest AG, Baxter International Inc., China Biologic Products, Inc., Celgene, Grifols SA, Mitsubishi Tanabe Pharma, CSL Behring LLC, Octapharma AG, Novozymes A/S, and Sigma-Aldrich Co.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of albumin market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount